Aggregated price index with volume information
Summary:
- Medical Specialties stocks up 2.7% on average while median return up 2.1% in a day
- Medical Specialties stocks up 1.6% on average while median return up 1.2% in a week
- Medical Specialties stocks up 0.8% on average while median return up -0.1% in a month
- When average return is significantly different from median return, this implies an asymmetry - composite return is driven by some outliners.
Aggregated price index (close) is based on equal weighted constituencies returns. Average short volume and average total volumes are averaged across all volume data among constituencies.
- 1M winners are : Winners for past month are $NTRB 66.7%, $BEAT 59.7%, $CCEL 55.4%, $STIM 47.7%, $TNDM 29.1%
- 1M losers are : Losers for past month are $NEPH -32.2%, $APYX -37.1%, $SMLR -41.1%, $OM -42.0%, $CUTR -47.3%
- 1W winners are : Winners for past week are $NTRB 65.3%, $CCEL 32.4%, $IRIX 22.9%, $DCTH 19.8%, $INGN 15.6%
- 1W losers are : Losers for past week are $NNOX -10.6%, $PLSE -11.0%, $BWAY -11.0%, $APYX -23.8%, $CUTR -34.1%
Correlation Analysis
Index correlation analysis
Correlation for the past month is 11.9%, for the past 3 months is 14.9%
In the past month for a 5 days rolling window, the highest corrrelation is 22.7%, the lowest correlation is -0.0%, the latest correlation is 16.6%
When a correlation deviated from the normal level and goes lower or even negative, it indicates some of stocks have deviated from the normal direction of the group. The deviation could reverse if long term level of correlation was at a higher level. It creates trading opportunities and deserves study whether the deviation is idiosyncratic or systematic.
Among pairwise correlation, the highest correlation is 84.4% between A and BRKR
The lowest correlation is -71.4% between BEAT and CDMO
In this article, we will take a detailed look at Corporate Insiders Are Selling These 10 Small-Cap Stocks. For a quick overview of such stocks, read our article Corporate Insiders Are Selling These 5 Small-Cap Stocks. When the inflation crisis started and the Federal Reserve began raising interest rates, investors were quick to exit small-cap stocks which are deemed […]
MALVERN, Pa., March 27, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the granting of inducement awards of Restricted Stock Units representing a total of 135,000 shares of the Company’s common stock (RSUs) to eleven new non-executive employees. In accordance with NASDAQ Listing Rule
Novocure stock surged Wednesday after its medtech device nearly doubled the length of time patients with brain tumors lived before worsening.
SALT LAKE CITY, March 27, 2024--Varex Imaging Corporation (Nasdaq: VREX) today announced it has entered into a senior secured revolving credit agreement (the "RLOC Facility") for an initial aggregate principal amount of up to $155 million. Zions Bancorporation, N.A. ("Zions") acted as lead arranger and bookrunner for the new RLOC Facility. Simultaneously, Varex terminated its existing senior secured asset-based revolving credit agreement.
Shockwave Medical shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Shares of Trump Media surge for a second day, GameStop’s fiscal fourth-quarter revenue misses analysts’ estimates, Merck’s treatment for pulmonary arterial hypertension receives FDA approval, and Cintas raises fiscal 2024 guidance.
Accuray (ARAY) announces the latest data that supports the use of its CyberKnife System in the treatment of recurrent prostate cancer with stereotactic body radiation therapy.
Stryker's (SYK) latest addition to its Gamma legacy is expected to streamline workflows and enhance usability.
IRIDEX Corporation (NASDAQ:IRIX) Q4 2023 Earnings Call Transcript March 26, 2024 IRIDEX Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and thank you for standing by. Welcome to IRIDEX Q4 2023 Earnings Conference Call. At this time, all […]